SCHEMBL3957233

SCHEMBL3957233

O=C1NC(=O)[C@@]2(C(=O)Nc3ccc(F)cc32)N1Cc1cc(Cl)nc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
AKR1B1 P15121 4/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HTR7 P34969 3/20 0.34
NPSR1 Q6W5P4 1/20 0.34
EGFR P00533 2/20 0.33
RAB9A P51151 1/20 0.32
PGR P06401 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
MDM2 Q00987 1/20 0.32
PLK4 O00444 2/20 0.32
AURKB Q96GD4 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3957230 0.78 ALDH1A1 (0.39) CYP1A2MAPTCYP2C19KMT2AAKR1B1
SCHEMBL4976851 0.74 TRAP1 (0.39) CYP1A2MAPTCYP2C19KMT2AAKR1B1
SCHEMBL3950564 0.74 CYP1A2 (0.43) CYP1A2MAPTCYP2C19KMT2AAKR1B1
SCHEMBL4979292 0.74 CYP1A2 (0.43) CYP1A2MAPTCYP2C19KMT2AAKR1B1
SCHEMBL3954631 0.73 IDO1 (0.41) MAPTKMT2AAKR1B1
SCHEMBL5135636 0.71 DAO (0.37) CYP1A2MAPTCYP2C19KMT2AAKR1B1
SCHEMBL3952569 0.70 OPRM1 (0.44) CYP1A2MAPTCYP2C19KMT2AAKR1B1
SCHEMBL4169552 0.66 AKR1B1 (0.45) AKR1B1
SCHEMBL4979612 0.66 TP53 (0.39) CYP1A2MAPTCYP2C19KMT2AAKR1B1
SCHEMBL4979242 0.63 POLB (0.43) CYP1A2MAPTCYP2C19KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013216-A2 NOVEL SPIRO [IMIDAZOLIDINE-4, 3' -INDOLE] 2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 AstraZeneca AB (SE) 2009-01-14 EP claimed
WO-2007091948-A2 NOVEL SPIRO [IMIDAZOLIDINE-4, 3´-INDOLE] 2, 2´,5´(1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 ASTRAZENECA AB (SE) 2007-08-16 WO claimed